ipratropium bromide monohydrate - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
AERON 250 ipratropium bromide (as monohydrate) 250 microgram/mL inhalation ampoule
AUST R: 98647
Active ingredients:
ipratropium bromide monohydrate

Dosage form:
Inhalation, conventional

Sponsor:
Viatris Pty Ltd

Phone:
1800 314 527

From
05 Oct 2021
to
21 Oct 2022

Shortage status:
Current

Availability:
Unavailable

Reason:
Manufacturing

Management action:
Alternate strength available

AERON 500 ipratropium bromide (as monohydrate) 500 microgram/mL inhalation ampoule
AUST R: 98648
Active ingredients:
ipratropium bromide monohydrate

Dosage form:
Inhalation, conventional

Sponsor:
Viatris Pty Ltd

Phone:
1800 314 527

From
01 Jan 2022
to
21 Oct 2022

Shortage status:
Current

Availability:
Limited Availability

Reason:
Manufacturing

Management action:
Alternative generic products are available.

ATROVENT UNIT DOSE VIALS ipratropium bromide 250 micrograms/1 mL (as monohydrate) conventional inhalation ampoule
AUST R: 17909
Active ingredients:
ipratropium bromide monohydrate

Dosage form:
Inhalation, conventional

Sponsor:
Boehringer Ingelheim Pty Ltd

Phone:
1800 226 315

From
03 Oct 2022
to
01 Nov 2022

Shortage status:
Anticipated

Availability:
Available

Reason:
Unexpected increase in consumer demand

Management action:
Alternative generic products are available.

APO-IPRATROPIUM ipratropium bromide anhydrous 250 microgram/mL inhalation ampoule
AUST R: 151089
Active ingredients:
ipratropium bromide monohydrate

Dosage form:
Inhalation, conventional

Sponsor:
Aspen Pharma Pty Ltd

Phone:
1300659646

Deletion from market:
30 Apr 2022

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability

APO-IPRATROPIUM ipratropium bromide anhydrous 500 microgram/mL inhalation ampoule
AUST R: 151090
Active ingredients:
ipratropium bromide monohydrate

Dosage form:
Inhalation, conventional

Sponsor:
Aspen Pharma Pty Ltd

Phone:
1300659646

Deletion from market:
30 Apr 2022

Shortage status:
Discontinued

Availability:
Unavailable

Reason:
Commercial Changes / Commercial viability